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Abstract
Background: To adequately assess individual studies and synthesize quantitative research on
weight loss studies, transparent reporting of data is required. The authors examined the reporting
quality of randomized trials in the weight loss literature, focusing exclusively on subject
characteristics as they relate to enrollment, allocation, and follow-up.
Methods: An extensive literature review, which included a computerized search of the MEDLINE
database, manual searches of bibliographic references, and cross-referencing of 92 review articles
was conducted. A checklist, based on CONSORT recommendations, was used to collect
information on whether or not authors reported age, gender, co-morbid disease, medication use,
race/ethnicity, and postmenopausal status. Also tracked was whether or not initial and final sample
size was reported and stratified by gender.
Results:  Of 604 possible articles, 231 articles met eligibility criteria. Important subject
characteristics were not reported as the following breakdown indicates: age (11%), gender (4%),
race/ethnicity (86%), co-morbid disease states (34%), and medication use (92%). Additionally, 21%
of articles failed to report initial sample size by gender while 69% neglected to report final sample
size by gender.
Conclusion: Inadequate reporting can create difficulties with interpretation and can lead to biased
results receiving false credibility. The quality of reporting for weight loss studies needs considerable
improvement.
Background
Current statistics indicate that approximately 64.5% of US
adults can be considered overweight while 30.5% can be
classified as obese [1]. Obesity is also linked to a variety of
chronic diseases, and is associated with approximately
300,000 deaths each year and annual economic costs of
over $117 billion [2]. According to the latest Behavioral
Risk Factor Surveillance Survey (BRFSS) data, obesity and
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overweight continue to be major pubic health concerns,
and reports indicate that no state had met the Healthy
People 2010 objective of reducing obesity to 15% [3]. As
a result, there is need for a strong evidence base for pre-
vention and treatment strategies.
Systematic reviews can offer the most reliable sources of
information on which to develop guidelines and base
treatment policy. However, such reviews need to contain
a high proportion of all relevant evidence, which relates
both to the need to find all trials and the need to analyze
data on all participants [4]. To improve the quality of
reporting for randomized controlled trials (RCTs) in the
overweight and obesity literature, as well as any interven-
tion trial, investigators are encouraged to publish reports
in clear and unambiguous language, accounting for all
events that occurred during the conduct of the investiga-
tion, and providing an accurate and thorough description
of subjects who were selected, excluded, withdrawn or did
not complete the study. Failing to report essential varia-
bles, such as subject characteristics, does not allow readers
to adequately judge the validity or applicability of the
study results, and may influence the interpretation of
findings [5].
In response to the need for quality reporting, a panel of
clinical investigators, epidemiologists, biostatisticians,
and journal editors published a statement called the Con-
solidation of the Standards of Reporting Trials (CON-
SORT), which is designed to improve the standard of
written reports of RCTs [6]. The CONSORT statement
includes a checklist of 21 items and a flow diagram that
can be used by authors to mark the page of the manuscript
in which each of the items is addressed. In addition, the
flow chart provides a detailed description of the progres-
sion of subjects through the intervention trial, from the
number of potentially eligible participants for inclusion
in the study to the number of intervention subjects in each
group who completed the trial [6]. Using a similar format,
we adapted the CONSORT form to examine the frequency
of explicit reporting of subject characteristics as they relate
to enrollment, allocation, and follow-up for weight loss
studies published in the diet and exercise literature.
Methods
For the present study, we used information collected from
a meta-analysis of the diet and exercise literature. The pri-
mary purpose of the meta-analysis was to statistically inte-
grate and analyze published research studies on the effects
of diet restriction only, diet restriction and exercise, or
exercise only on weight loss, body composition, fat distri-
bution, metabolism, and aerobic fitness. We examined
the frequency of explicit reporting of subject characteris-
tics (i.e., age, gender, co-morbid disease states, medication
use (in addition to intervention drug), race/ethnicity, and
postmenopausal status). We also examined whether or
not initial and final sample size was reported and if so, we
recorded if the final sample size was reported by gender.
Search strategy. With the assistance of a clinical medical
librarian, we developed search strategies, key words, and
check tags to begin our initial search for relevant articles
to include in the meta-analysis. We identified studies
from a computerized search of the MEDLINE database
(US National Library of Medicine) from 1966 – 2003,
manual searches of bibliographic references of relevant
published articles, and extensive cross-referencing and
manual searches of 92 review articles.
Overall study inclusion criteria
Subject types. We required that intervention trials must
study overweight or obese (BMI ≥  25 kg/m2) adult partic-
ipants (≥  18 years old). Ambulatory patients who were
kept on wards exclusively for study purposes were also
included. However, studies including pregnant women,
patients with serious medical conditions, military person-
nel, and trained or professional athletes were excluded.
Intervention types. For inclusion, trials were required to
meet each of the following criteria: 1) active intervention
trials with one group assigned to a weight-loss program
involving energy restriction, exercise (aerobic or weight
training) or both energy restriction and exercise; 2) out-
come measures included weight loss; however, weight
loss was not required to be a primary outcome; 3) the
minimum duration of the intervention for weight loss
must be greater than one day; and, 4) the article must be
published in the English language. Case studies, crossover
trials (due to possible carryover effects of weight reduc-
tion), and exploratory studies were excluded. We did not
require studies to have been conducted in the United
States. Pharmacotherapy, hormonal therapy, or surgical
treatment studies, which did not include a separate group
receiving a weight loss intervention (i.e., diet and/or exer-
cise) were not included in the review process.
Initial screening process. We independently screened all
records resulting from our MEDLINE search strategies and
manual searches by examining the titles and abstracts. We
rejected articles if we could determine from the title and/
or abstract that the study did not meet our selection crite-
ria. If we could not determine whether or not to reject the
article or if there was disagreement among reviewers, we
retrieved the full text of the article for further evaluation.
Quality control measures
To control for abstraction bias, we trained five graduate
research assistants to extract information from articles,
using sample articles. Reliability checks were completed
on the first several sample articles before graduateBMC Medical Research Methodology 2005, 5:9 http://www.biomedcentral.com/1471-2288/5/9
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students were allowed to code independently. On a
monthly basis thereafter, inter- and intra-rater reliability
checks were completed to control for drift. All research
assistants were required to attend weekly meetings with
the principal investigator and co-investigators to discuss
coding issues and to resolve coding disagreements.
To control for potential selection biases after our initial
screening procedure, we selected or rejected studies based
on an examination of the research design and methodol-
ogy. Acceptance or rejection for inclusion in the meta-
analysis was not based on the study's outcome. We
required coders to list specific reasons for all excluded
studies. In addition, we tried to enhance data reporting for
studies with missing covariate data by contacting authors
by email or letter.
Data entry quality control measures included the design
of screens to match the coding sheet, automatic range lim-
its placed on items entered, and queries to check for out-
liers. Values greater than two standard deviations from the
mean were checked against the article. In addition, a ran-
dom sampling of 58 articles (~25%) was pulled to check
for accuracy.
Standardized coding sheet for data abstraction. A separate
checklist was devised based on CONSORT recommenda-
tions and quality indicators suggested by other authors [6-
10]. Specific subject information was extracted from the
meta-analysis database to examine if investigators
reported age, race/ethnicity, and gender of their study sub-
jects. Coders also recorded whether or not investigators
reported the subjects' health status and presence of co-
morbidities (i.e., diabetes, cardiac problems, cancer, or
hypertension). Whether or not investigators reported
medication use by subjects, other than the intervention
drug, was also recorded. In addition, we tracked reporting
of the postmenopausal status of subjects in investigations
which included women 45 years or older. When analyzing
the reporting quality for initial and final sample size sep-
arated by gender, only studies that included a group(s)
consisting of both men and women were selected.
Statistical analysis
The frequency of reporting in the journal articles for the
selected variables was obtained by performing a proc fre-
quency using SAS (Version 8.2, Cary, NC). Results are pre-
sented as totals.
Results
Of the 604 randomized clinical trial articles that were
reviewed, 231 (38%) met eligibility criteria for the present
study. Figure 1 displays the frequency of articles included
in the analysis by year of publication. Of these, 123 (53%)
articles were randomized studies without a control group
and 108 (47%) were randomized controlled trials. Sev-
enty-six articles (33%) were dietary intervention only, 60
(26%) were exercise intervention only, and the remaining
95 articles (41%) included both exercise and dietary inter-
vention for weight loss.
Frequency of randomized trials published by year Figure 1
Frequency of randomized trials published by year.
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Contribution of journals
For this analysis, the American Journal of Clinical Nutri-
tion contributed the most articles that met the eligibility
criteria (47), followed by the International Journal of
Obesity (32), Medicine & Science in Sports & Exercise
(24), Journal of the American Medical Association (11),
Metabolism (11), New England Journal of Medicine (7),
Archives of Internal Medicine (6), and Journal of the
American Dietetics Association (6). In addition, 52 jour-
nals had 5 or fewer articles in this analysis.
Subject characteristics
Of the 231 articles that met eligibility criteria for the
present study, subjects' age was not reported in 25 (11%)
articles. Investigators of ten (4%) different studies failed
to report the gender of their study participants. Race and/
or ethnicity of study subjects were not reported in 199
(86%) studies. In addition, 78 (34%) studies failed to
report the health status (i.e., presence or absence of co-
morbidities) of their study subjects at baseline. Further,
medication use was not reported in 213 (92%) of the arti-
cles (Figure 2). For postmenopausal status, 89 articles
were included in the overall analysis with only 7 (8%)
studies that did not report the postmenopausal status of
their female subjects.
Sample size and attrition
Initial sample size was not reported in 14 (6%) studies
while final sample size was not reported in 133 (58%) of
the 231 eligible articles. When reporting initial and final
sample size by gender, 68 articles were included in the
analysis. Of the eligible articles, 14 (21%) did not report
initial sample size by gender while 47 (69%) failed to
report final sample size by gender (Figure 3).
Discussion
The present study evaluated the quality of reporting of RTs
and RCTs in the diet and exercise literature for weight loss,
focusing exclusively on subject characteristics, including
age, gender, race, health status, medication use, postmen-
opausal status, and attrition. Transparent reporting of
subject data is important in the scientific literature so that
readers can efficiently evaluate outcomes in RTs and RCTs.
Inadequate reporting creates numerous difficulties with
interpretation and can lead to biased conclusions. For
example, the effects of diet and/or exercise can vary based
upon an individual's age. Schwartz et al. 1991[11] com-
pared the effects of 6 months of endurance exercise (4
days/wk, 45 minutes/day, 85% of heart rate reserve) in
older (Mean = 67.5 yrs, SD = 5.8 yrs) versus younger
(Mean = 28.2 yrs, SD = 2.4 yrs) on body weight and
Proportion of selected subject characteristics not reported in randomized trials Figure 2
Proportion of selected subject characteristics not reported in randomized trials. Values reported are means. Co-morbid dis-
ease status included the reporting of diabetes, cardiac diseases, cancer, hypertension, or any other metabolic disease.
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composition. They found that older men had a 2.5 kg
reduction in body weight, a 2.3% decrease in percent
body fat, and a 2.4 kg decline in fat mass compared to no
changes in the younger individuals. The findings suggest
that subjects' age is an important determinant in the
response to exercise. However, despite the difference in
response to exercise based on the age of subjects, we
found that 11% of authors failed to report their subjects'
ages within their published report.
Reporting gender of the study participants is also impor-
tant as men and women respond differently to diet and/
or exercise treatments. For example, Donnelly et al. [12]
reported that following 16 months of verified, supervised
aerobic exercise at 45 minutes per day, 5 days per week
resulted in a decrease in body weight of 6% for the men
compared to no change in the women.
It also has been shown that individuals from different
races and/or ethnic background may respond differently
to diet and/or exercise. Jakicic et al. [13] reported that rest-
ing energy expenditure was lower in African-American
women (Mean = 7279 kJ/d, SD = 825 kJ/d) compared to
Caucasian women (Mean = 7807 kJ/d, SD = 854 kJ/d)
even after correcting for body weight and lean body mass.
The authors concluded that such differences might par-
tially explain the smaller weight losses typically seen in
African-American women when compared to Caucasian
women enrolled in a weight loss program. In a recent
meta-analysis on walking and resting blood pressure in
adults, the investigators reported that only 13% of their
included studies reported information on race [5]. In the
current investigation 86% of authors failed to report the
race/ethnicity of the subjects, which highlights the need
for caution when extrapolating findings from one popula-
tion to another.
In the present study, co-morbid health conditions of
study subjects were only marginally reported (66%) in the
literature. It is well known that certain disease states, such
as diabetes and cancer, affect metabolism [14-17], which
can influence the effect of diet and exercise on body com-
position. Closely related to the need for reporting health
conditions of study participants is the issue of medication
use. Davis et al. [18] determined the effects of taking an
antihypertensive medication (i.e., atenolol or chlortha-
lidone) compared to a placebo group combined with
weight loss. They found that at 6 months those taking
chlorthalidone lost (6.9 kg) the most weight compared to
either the placebo (4.4 kg) or atenolol (3.0 kg) groups.
They speculated that the group taking chlorthalidone
might have reduced appetite or increased fat mobilization
due to the volume depletion and increases in serum and
urinary catecholamines. However, despite the profound
effects that medication may have on body weight and
composition 92% of authors failed to report medication
use in our study. Without an adequate description of sub-
Proportion of articles that did not report initial and final sample size by group or gender in randomized trials Figure 3
Proportion of articles that did not report initial and final sample size by group or gender in randomized trials. Values reported 
are means.
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ject characteristics, readers are unable to judge the compa-
rability of study groups.
Menopause is associated with decreases in lean mass and
increases in fat-mass [19-22]. Therefore, post-menopausal
status and the associated decline in estrogens, androgens,
and other hormones may significantly influence the
effects of dietary/exercise interventions on body composi-
tion. It appears from the present study the majority of
investigators (92%) of dietary/exercise studies report post-
menopausal status of their subjects.
Attrition may threaten the internal and external validity of
the scientific literature as well as the efficacy of a specific
dietary/exercise intervention [23,24]. For example, failure
to report the number of dropouts and completers prevents
the reader from calculating attrition rates for different
experimental conditions, which can result in an overesti-
mate of treatment effectiveness. In the present study, we
found that end of study sample size was not reported in
the majority (58%) of studies. Without knowledge of the
number of subjects who were lost to follow-up, readers
are unable to judge the effectiveness of a clinical treatment
or ascertain whether or not a research finding has practical
significance.
Conclusion
In the present critical appraisal of the methodological
quality of weight loss studies, we found major shortcom-
ings in the reporting of subject characteristics as they
relate to enrollment, allocation, and follow-up in trials
that evaluated diet and exercise interventions. Many stud-
ies did not report variables that may explain some of the
variance in outcomes. These findings are consistent with
those of similar studies, which indicate inadequate report-
ing of subject characteristics [5,25] and reveal that poor
adherence to published standards of reporting is common
[26]. Clearly, additional attention should be paid to
ensure compliance with reporting standards for diet and
exercise intervention studies.
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